Physician profile
Erica J Ormeno
NPI 1114353364
$6,512.88
in general payments reported to CMS, 2019-2025
33 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,212 · 2022: $614 · 2023: $1,850 · 2024: $1,355 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,687.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $913.69 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $608.00 | 2021-2025 | Wegovy, Saxenda, Ozempic |
| Abbvie INC. | $600.03 | 2021-2025 | |
| Lilly USA, LLC | $570.73 | 2022-2024 | Omvoh, Jardiance, Mounjaro |
| Abiomed | $363.03 | 2024-2025 | Impella |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $360.66 | 2021-2024 | Cycloset, Xifaxan |
| Abbott Laboratories | $322.74 | 2021-2025 | Freestyle Libre 3, Ensite Precision, Freestyle Libre 2 |
| Si-Bone, INC. | $261.29 | 2024-2025 | |
| Intuity Medical INC | $252.09 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Boston Scientific Corporation | $248.48 | 2022-2025 | Watchman Flx |
| Axsome Therapeutics, INC. | $239.78 | 2025 | Auvelity, Symbravo |
| Acadia Pharmaceuticals INC | $219.61 | 2024-2025 | Daybue |
| Silk Road Medical, INC. | $142.90 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.10 | 2022-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $137.86 | 2024 | Spravato |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $136.85 | 2022-2023 | Evenity |
| Shield Therapeutics INC | $134.38 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $124.99 | 2023 | Gemtesa |
| Edwards Lifesciences Corporation | $109.33 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Insulet Corporation | $90.11 | 2025 | Omnipod |
| Gilead Sciences, INC. | $88.36 | 2023-2025 | Livdelzi, Epclusa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.16 | 2021 | |
| Medtronic, INC. | $77.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $57.33 | 2021-2023 | Livalo, Seglentis |
| Exact Sciences Corporation | $43.78 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $37.50 | 2023-2024 | |
| Glaxosmithkline, LLC. | $31.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.66 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $20.88 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.84 | 2022 | |
| Inari Medical, INC. | $20.17 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Eisai INC. | $18.92 | 2021 | |
| Horizon Therapeutics Plc | $15.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Ormeno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.